Loading…
Eton Pharmaceuticals, Inc. is projected to rise to $57.23 by 2027, a +23% move from its current price of $46.42. ETON is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $44.88 | $46.42 | $48.02 | 0.00% |
| Aug 3 | $44.25 | $46.42 | $48.70 | +0.01% |
| Aug 4 | $43.78 | $46.42 | $49.23 | +0.01% |
| Aug 5 | $43.39 | $46.42 | $49.68 | +0.01% |
| Aug 6 | $43.04 | $46.43 | $50.08 | +0.01% |
| Aug 7 | $42.73 | $46.43 | $50.44 | +0.02% |
| Aug 8 | $42.45 | $46.43 | $50.78 | +0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $42.45 | $46.43 | $50.78 | +0.02% |
| Week 2 | $40.91 | $46.44 | $52.71 | +0.04% |
| Week 3 | $39.77 | $46.44 | $54.24 | +0.05% |
| Week 4 | $38.83 | $46.45 | $55.57 | +0.07% |
| Week 5 | $38.03 | $46.46 | $56.76 | +0.09% |
| Week 6 | $37.32 | $46.47 | $57.87 | +0.11% |
| Week 7 | $36.67 | $46.48 | $58.90 | +0.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1.
The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
ETON is currently trading with a price of $46.66 and a market capitalization of $1.28B, and it holds a rank of 2274. The stock’s near-term forecast shows a neutral stance for 2026, with a 2026 average price of $46.66, a low of $14.35, and a high of $58.24, and a forecasted ROI of 0. The longer-term outlook remains bullish, with rising average prices across the years and progressively higher ROI, culminating in substantial upside by 2050.
The multi-year path implies meaningful upside potential relative to the current level as the years unfold.
A major floor 51.4% below — a decisive break under it would weaken the trend.
The nearest floor, 30.0% below — buyers have tended to step in here.
The nearest ceiling, 5.6% above — a clean break opens room to run.
A major ceiling 27.5% above — clearing it would confirm fresh momentum.
Key ETON support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ETON market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $46.51 | Sell | $46.50 | Sell |
| MA 10 | $44.71 | Buy | $44.80 | Buy |
| MA 20 | $41.29 | Buy | $42.08 | Buy |
| MA 50 | $35.97 | Buy | $37.05 | Buy |
| MA 100 | $30.56 | Buy | $31.97 | Buy |
| MA 200 | $23.65 | Buy | $26.49 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.28 | Neutral |
| Stoch RSI (14) | 37.25 | Neutral |
| CCI (20) | 96.42 | Neutral |
| Williams %R (14) | -22.04 | Info |
| MACD (12,26,9) | 0.50 | Buy |
| ROC (12) | 20.57 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 77.96 | Neutral |
| TRIX (15) | 1.13 | Buy |
| Awesome (5,34) | 8.13 | Buy |
| Ultimate (7,14,28) | 65.43 | Neutral |
| Momentum (10) | 4.10 | Buy |
| Aroon Osc (25) | 96.00 | Buy |
| Hull MA (9) | 48.96 | Sell |
| ADX (14) | 36.82 | Buy |
| ATR (14) | 1.37 | Info |
The 30-day technical picture shows a bullish overall sentiment for the asset. The RSI14 sits at 60, indicating room for upside without becoming overbought. The price is above the SMA50 of $34.44 and above the SMA200 of $22.99, suggesting a constructive trend.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $14.35 | $46.42 | $57.64 | 0% | Neutral | |
| $44.65 | $57.23 | $78.14 | +23% | Bullish | |
| $57.64 | $76.59 | $109.39 | +65% | Bullish | |
| $67.22 | $92.03 | $136.11 | +98% | Bullish | |
| $81.45 | $114.50 | $174.35 | +147% | Bullish | |
| $87.10 | $125.45 | $195.89 | +170% | Bullish | |
| $87.52 | $128.94 | $205.93 | +178% | Bullish | |
| $99.54 | $149.81 | $244.17 | +223% | Bullish | |
| $107.95 | $165.82 | $275.35 | +257% | Bullish | |
| $137.16 | $214.86 | $362.99 | +363% | Bullish | |
| $184.23 | $315.79 | $573.20 | +580% | Bullish | |
| $337.11 | $678.25 | $1,364.97 | +13.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $14.35 | $46.42 | $54.26 | +0.00% |
| September 2026 | $37.84 | $45.09 | $55.48 | -2.86% |
| October 2026 | $38.72 | $46.53 | $57.99 | +3.18% |
| November 2026 | $37.85 | $45.80 | $57.69 | -1.56% |
| December 2026 | $37.23 | $45.33 | $57.64 | -1.02% |
Click any year to see its month-by-month ETON forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ETON price prediction for 2026 points to an average of $46.42 (low $14.35, high $57.64) — a potential gain of 0% on today's $46.42. A consolidation phase looks the most probable path here.
In 2027, ETON is projected to trade between $44.65 and $78.14, averaging $57.23 — a potential gain of +23% from today's $46.42. That is up +23% on the projected 2026 average. Momentum favours further upside here.
Eton Pharmaceuticals, Inc.'s 2028 outlook centres on $76.59, within a $57.64 to $109.39 range. That is up +34% on the projected 2027 average. That marks a +65% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ETON could reach as high as $136.11, with a base case around $92.03 and support toward $67.22 — roughly +98% from $46.42. Momentum favours further upside here.
Expect ETON to range from $81.45 to $174.35 through 2030. The $114.50 average target implies a +147% move from current prices. That is up +24% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ETON price prediction for 2031 points to an average of $125.45 (low $87.10, high $195.89) — a potential gain of +170% on today's $46.42. Momentum favours further upside here.
In 2032, ETON is projected to trade between $87.52 and $205.93, averaging $128.94 — a potential gain of +178% from today's $46.42. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Eton Pharmaceuticals, Inc.'s 2033 outlook centres on $149.81, within a $99.54 to $244.17 range. That is up +16% on the projected 2032 average. That marks a +223% change versus current levels. Momentum favours further upside here.
By 2034, ETON could reach as high as $275.35, with a base case around $165.82 and support toward $107.95 — roughly +257% from $46.42. Buyers look set to stay in control over this stretch.
Expect ETON to range from $137.16 to $362.99 through 2035. The $214.86 average target implies a +363% move from current prices. That is up +30% on the projected 2034 average. Momentum favours further upside here.
The ETON price prediction for 2040 points to an average of $315.79 (low $184.23, high $573.20) — a potential gain of +580% on today's $46.42. Buyers look set to stay in control over this stretch.
In 2050, ETON is projected to trade between $337.11 and $1,364.97, averaging $678.25 — a potential gain of +13.6x from today's $46.42. That is up +115% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ETON today (≈ 21.542439 ETON) could be worth
$14,611.14
+$13,611.14 (+1361%) by 2050 · US Dollar
Based on the average projected ETON price of $678.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ETONwould be worth at today's price.
$1,000 invested in ETON on Jul 31, 2025 (≈ 70.62147 ETON) would be worth
$3,278.25
+$2,278.25 (+227.8%) today · 3.28× · US Dollar
Based on a ETON entry price of $14.16 vs. today's $46.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $42.59 | $1,089.93 | +9.0% |
| 1 month ago | $36.63 | $1,267.27 | +26.7% |
| 3 months ago | $28.9 | $1,606.23 | +60.6% |
| 6 months ago | $15.17 | $3,059.99 | +206.0% |
| 1 year ago | $14.16 | $3,278.25 | +227.8% |
| All time (5.0y) ago | $5.74 | $8,087.11 | +708.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ETON forecast.
Our base-case forecast reaches $93.00 around 2030.
Implied market cap at $93.00: $2.55B
Looking across the multi-year forecast, the average price rises from 2027 onward, with 2027 at $58.16 and an ROI of 24.6%. The sequence continues with 2028 at $76.82 (ROI 64.6%), 2029 at $91.71 (ROI 96.5%), and 2030 at $112.76 (ROI 141.7%). The bullish momentum extends through 2031 ($123.38, ROI 164.4%), 2032 ($128.22, ROI 174.8%), and 2033 ($148.98, ROI 219.3%), then into 2034 ($165.85, ROI 255.4%) and 2035 ($211.39, ROI 353.1%).
The forecast grows more pronounced in the 2040s, with 2040 averaging $311.88 (ROI 568.4%), and the long-range 2050 forecast showing an average of $665.23 (ROI 1325.7%) with a max of $1,280.65. These figures reflect a sustained bullish arc across the horizon, albeit with the usual caveat that forecasts are not guarantees and depend on a range of factors.
Tap a question to reveal the answer.
The average forecast for 2030 is $112.76 with a min of $82.03 and a max of $167.52; ROI 141.7%.
Forecasts show bullish sentiment in multiple years, including 2027 at $58.16 (ROI 24.6%), 2028 at $76.82 (ROI 64.6%), 2029 at $91.71 (ROI 96.5%), and 2030 at $112.76 (ROI 141.7%), suggesting upside potential though outcomes are not guaranteed.
Yes. The 2033 forecast lists an average of $148.98 and a max of $235.67, indicating the possibility of a price above $200 in that year.
The 2040 forecast shows a min of $191.10, an average of $311.88, and a max of $545.18; ROI 568.4%.
The 2050 forecast shows a min of $356.07, an average of $665.23, and a max of $1,280.65; ROI 1325.7%.
Eton Pharmaceuticals, Inc. Community Discussion
0Share your Eton Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.